Market conditions are Bullish in a Bear Market as of 2023-01-26. This means traders and investors should consider trading with a Neutral or Bullish bias by buying stocks and setting tight stops. The rank of the Bear Market is -10.80 which indicates the current market conditions are Extreme, Risk of a reversal is high. The […]
Read MoreMarket conditions are Bullish in a Bear Market as of 2023-01-25. This means traders and investors should consider trading with a Neutral or Bullish bias by buying stocks and setting tight stops. The rank of the Bear Market is -11.05 which indicates the current market conditions are Extreme, Risk of a reversal is high. The […]
Read MoreMarket conditions are Bullish in a Bear Market as of 2023-01-24. This means traders and investors should consider trading with a Neutral or Bullish bias by buying stocks and setting tight stops. The rank of the Bear Market is -11.25 which indicates the current market conditions are Extreme, Risk of a reversal is high. The […]
Read MoreTrade Setup CPS Technologies Corporation produces and sells advanced material solutions to the transportation, automotive, energy, computing/internet, telecommunication, aerospace, defense, and oil and gas markets. The company primarily offers metal matrix composites that are a combination of metal and ceramic, such as baseplates for various applications, including motor controllers used in electric trains, subway cars, […]
Read MoreTrade Setup Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the United States, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases […]
Read MoreTrade Setup Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of oncology drug candidates for the treatment of highly resistant tumors and viruses in the United States. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers […]
Read MoreTrade Setup electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore […]
Read MoreTrade Setup Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for oncology and rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, metastatic […]
Read MoreTrade Setup VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older; and ZILXI for the treatment of inflammation lesions of papulopustular rosacea […]
Read MoreTrade Setup Harbor Diversified, Inc., together with its subsidiaries, provides air transportation services in the Unites States. It also acquires flight equipment for the purpose of leasing; and provides flight equipment financing services. As of December 31, 2020, it owned and operated a fleet of 64 regional jets. The Company was formerly known as Harbor […]
Read MoreTrade Setup Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood […]
Read MoreTrade Setup iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma and idiopathic pulmonary […]
Read MoreTrade Setup Gaucho Group Holdings, Inc., through its subsidiaries, invests in, develops, and operates real estate projects in Argentina. The company also owns and operates Algodon Mansion, a luxury boutique hotel in Buenos Aires; and Algodon Wine Estates, a winery and golf resort with tennis courts, dining, and hotel amenities in Mendoza, as well as […]
Read MoreTrade Setup LightInTheBox Holding Co., Ltd. operates as a cross-border e-commerce platform that delivers products directly from manufacturers to its customers worldwide. The company provides customized, special occasion, and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home garden products, electronics and communication devices, and other products. It also […]
Read MoreTrade Setup Infobird Co., Ltd operates as a software-as-a-service (SaaS) provider of artificial intelligence (AI) enabled customer engagement solutions in the People’s Republic of China. It offers standard and customized customer relationship management cloud-based services, such as SaaS, and business process outsourcing services to its clients. The company also provides AI-powered cloud-based sales force management […]
Read More